Matthew J Peerce

Array ( [id] => 7502266 [patent_doc_number] => 20110263862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'PIPERIDINE DERIVATIVE, PIPERAZINE DERIVATIVE AND AGENT FOR TREATMENT OF DISEASE INVOLVING CENTRAL NERVOUS SYSTEM DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/126158 [patent_app_country] => US [patent_app_date] => 2009-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6049 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263862.pdf [firstpage_image] =>[orig_patent_app_number] => 13126158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9703965 [patent_doc_number] => 08829027 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use' [patent_app_type] => utility [patent_app_number] => 13/124259 [patent_app_country] => US [patent_app_date] => 2009-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25672 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13124259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064382 [patent_doc_number] => 20110201632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => '2,5-Disubstituted Piperidine Orexin Rceptor Antagonists' [patent_app_type] => utility [patent_app_number] => 13/124901 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15694 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201632.pdf [firstpage_image] =>[orig_patent_app_number] => 13124901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9020676 [patent_doc_number] => 08530662 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-10 [patent_title] => 'Pyridyltetrahydropyridines and pyridylpiperidines, and method of manufacturing them' [patent_app_type] => utility [patent_app_number] => 12/576321 [patent_app_country] => US [patent_app_date] => 2009-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8970 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12576321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239398 [patent_doc_number] => 08604190 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Hetero isonipecotic modulators of vanilloid VR1 receptor' [patent_app_type] => utility [patent_app_number] => 12/574444 [patent_app_country] => US [patent_app_date] => 2009-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11206 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12574444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6550210 [patent_doc_number] => 20100016600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'N- and O-Substituted 4-[2-(Diphenylmethoxy)-Ethyl]-1-[(Phenyl)Methyl]Piperdine Analogs and Methods of Treating CNS Disorders Therewith' [patent_app_type] => utility [patent_app_number] => 12/568503 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13156 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016600.pdf [firstpage_image] =>[orig_patent_app_number] => 12568503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6190147 [patent_doc_number] => 20110172431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'PROCESS FOR PRODUCING 1-SUBSTITUTED TRANS-4-(SUBSTITUTED AMINO) PIPERIDIN-3-OL' [patent_app_type] => utility [patent_app_number] => 13/119852 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12527 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172431.pdf [firstpage_image] =>[orig_patent_app_number] => 13119852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6347928 [patent_doc_number] => 20100021395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'CRYSTALLINE FORMS OF A BIPHENYL COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/563727 [patent_app_country] => US [patent_app_date] => 2009-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 22166 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20100021395.pdf [firstpage_image] =>[orig_patent_app_number] => 12563727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6596780 [patent_doc_number] => 20100048622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'CRYSTALLINE FORMS OF A BIPHENYL COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/563788 [patent_app_country] => US [patent_app_date] => 2009-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 22146 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048622.pdf [firstpage_image] =>[orig_patent_app_number] => 12563788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6498342 [patent_doc_number] => 20100010229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'FEXOFENADINE POLYMORPH' [patent_app_type] => utility [patent_app_number] => 12/562725 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2944 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20100010229.pdf [firstpage_image] =>[orig_patent_app_number] => 12562725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6190013 [patent_doc_number] => 20110172297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'Oxopiperdinyl And Pyranyl Sulfonamides and Pharmaceutical Compositions Thereof' [patent_app_type] => utility [patent_app_number] => 13/061684 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38625 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172297.pdf [firstpage_image] =>[orig_patent_app_number] => 13061684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6376932 [patent_doc_number] => 20100076198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'Crystalline forms of Fentanyl Alkaloid' [patent_app_type] => utility [patent_app_number] => 12/560614 [patent_app_country] => US [patent_app_date] => 2009-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7250 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20100076198.pdf [firstpage_image] =>[orig_patent_app_number] => 12560614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6163328 [patent_doc_number] => 20110160244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'PHENYLPIPERIDINE MODULATORS OF MU-OPIOID RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/561030 [patent_app_country] => US [patent_app_date] => 2009-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10596 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160244.pdf [firstpage_image] =>[orig_patent_app_number] => 12561030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6629640 [patent_doc_number] => 20100004285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'POLYMORPH OF 4-[2-[4-[1-(2-ETHOXYETHYL)-1H-BENZIMIDAZOLE-2-YL]-1-PIPERIDINYL]ETHYL]-alpha alpha-DIMETHYL-BENZENEACETIC ACID' [patent_app_type] => utility [patent_app_number] => 12/561148 [patent_app_country] => US [patent_app_date] => 2009-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2272 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004285.pdf [firstpage_image] =>[orig_patent_app_number] => 12561148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10141413 [patent_doc_number] => 09174201 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-03 [patent_title] => 'Method for the continuous production of an amine using an aluminum—copper catalyst' [patent_app_type] => utility [patent_app_number] => 13/119948 [patent_app_country] => US [patent_app_date] => 2009-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9203 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 326 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13119948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6257800 [patent_doc_number] => 20100029720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'Carboxamide Derivatives As Muscarinic Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 12/556285 [patent_app_country] => US [patent_app_date] => 2009-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63037 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029720.pdf [firstpage_image] =>[orig_patent_app_number] => 12556285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6376922 [patent_doc_number] => 20100076196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'PROCESS FOR THE PREPARATION OF ILOPERIDONE' [patent_app_type] => utility [patent_app_number] => 12/555066 [patent_app_country] => US [patent_app_date] => 2009-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1483 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20100076196.pdf [firstpage_image] =>[orig_patent_app_number] => 12555066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7488503 [patent_doc_number] => 20110251397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'METHOD FOR PREPARATION OF 3-METHYLPYRIDINE' [patent_app_type] => utility [patent_app_number] => 13/119059 [patent_app_country] => US [patent_app_date] => 2009-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1172 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251397.pdf [firstpage_image] =>[orig_patent_app_number] => 13119059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7757051 [patent_doc_number] => 20120029018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => '9-SUBSTITUTED PHENANTHRENE BASED TYLOPHORINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/059426 [patent_app_country] => US [patent_app_date] => 2009-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5261 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20120029018.pdf [firstpage_image] =>[orig_patent_app_number] => 13059426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6223156 [patent_doc_number] => 20100056574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'Crystalline Forms of Sufentanil' [patent_app_type] => utility [patent_app_number] => 12/546898 [patent_app_country] => US [patent_app_date] => 2009-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5503 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056574.pdf [firstpage_image] =>[orig_patent_app_number] => 12546898 [rel_patent_id] =>[rel_patent_doc_number] =>)